JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB137872

Anti-LEF1 抗体 [EPR2029Y]

Anti-LEF1 antibody [EPR2029Y]

  • BOND RX™ Validated
  • 20ul selling size
  • RabMAb
  • Recombinant
  • KO Validated
  • 了解详情

5

(3 Reviews)

|

(96 Publications)

Anti-LEF1 antibody [EPR2029Y] (ab137872) is a rabbit monoclonal antibody detecting LEF1 in Western Blot, Flow Cytometry (Intra), Flow Cytometry, IP, IHC-P, ICC/IF. Suitable for Human, Mouse, Rat.

- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 60 publications

查看别名

Lymphoid enhancer-binding factor 1, LEF-1, T cell-specific transcription factor 1-alpha, TCF1-alpha, LEF1

20 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LEF1 antibody [EPR2029Y] (AB137872)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LEF1 antibody [EPR2029Y] (AB137872)

ab137872 staining LEF1 in paraffin embedded human melanoma tissue by Immunohistochemistry. Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins.  Samples were incubated with primary antibody at 1/2000 dilution for 30 mins at room temperature. A ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101) was used as the secondary antibody. Hematoxylin was used as a counterstain. The immunostaining was performed on a Leica Biosystems BOND® RX instrument.

Flow Cytometry (Intracellular) - Anti-LEF1 antibody [EPR2029Y] (AB137872)
  • Flow Cyt (Intra)

Lab

Flow Cytometry (Intracellular) - Anti-LEF1 antibody [EPR2029Y] (AB137872)

Flow cytometry overlay histogram showing left Jurkat positive cells and right negative HeLa stained with ab137872 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilised with 0.1% PBS-Triton X-100 for 15 min. The cells were then incubated in 1x PBS containing 10% normal goat serum to block non-specific protein-protein interaction followed by the antibody (ab137872) (1x 106 in 100μl at 0.2μg/ml (1/11500 dilution)) for 30min at 22°C.The secondary antibody Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed was incubated at 1/4000 for 30min at 22°CIsotype control antibody (black line) was Recombinant Rabbit IgG monoclonal [EPR25A] - Isotype Control used at the same concentration and conditions as the primary antibody. Unlabelled sample (blue line) was also used as a control.Acquisition of >5000 events were collected using a 50 mW Blue laser (488nm) and 525/40 bandpass filter.This antibody gave a positive signal in Jurkat Fixed with 4% formaldehyde (10 min) / permeabilised with 0.1% PBS-Triton X-100 for 15 min under the same conditions.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LEF1 antibody [EPR2029Y] (AB137872)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LEF1 antibody [EPR2029Y] (AB137872)

ab137872 staining LEF1 in paraffin embedded human thymona tissue by Immunohistochemistry. Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins.  Samples were incubated with primary antibody at 1/2000 dilution for 30 mins at room temperature. A ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101) was used as the secondary antibody. Hematoxylin was used as a counterstain. The immunostaining was performed on a Leica Biosystems BOND® RX instrument.

Immunocytochemistry/ Immunofluorescence - Anti-LEF1 antibody [EPR2029Y] (AB137872)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-LEF1 antibody [EPR2029Y] (AB137872)

Immunofluorescence staining of Jurkat (Human T cell leukemia cell line from peripheral blood) cells with purified ab137872 at a working dilution of 1 in 500 counter-stained with DAPI. Tubulin was stained with mouse anti-tubulin at a dilution of 1/1000 (ab7291) and Alexa Fluor® 594 goat anti-mouse at a dilution of 1/500 (ab150120) . The secondary antibody was ab150077 Alexa Fluor® 488 goat anti rabbit used at a dilution of 1 in 500. The cells were fixed in 4% PFA and permeabilized using 0.1% Triton X 100.

The negative controls are shown in the bottom middle and right hand panels - for the first negative control purified ab137872 was used at a dilution of 1/200 followed by an Alexa Fluor® 555 goat anti-mouse antibody at a dilution of 1/500 and for the second negative control mouse primary antibody (ab7291) and anti-rabbit secondary antibody (ab15007) were used.

Flow Cytometry (Intracellular) - Anti-LEF1 antibody [EPR2029Y] (AB137872)
  • Flow Cyt (Intra)

Lab

Flow Cytometry (Intracellular) - Anti-LEF1 antibody [EPR2029Y] (AB137872)

Intracellular flow cytometric analysis of Jurkat cell line (human T cell leukemia T lymphocyte) fixed with 4% paraformaldehyde and permeabilized with 90% methanol labeling LEF1 with ab137872 at 1/600 dilution (red). This is compared with a Rabbit monoclonal IgG (ab172730) - Isotype control (black) and a unlabeled control (cells without incubation with primary antibody and secondary antibody) (blue). Goat anti-rabbit IgG (Alexa Fluor®488) was used as the secondary antibody.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LEF1 antibody [EPR2029Y] (AB137872)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LEF1 antibody [EPR2029Y] (AB137872)

Immunohistochemical staining of paraffin embedded human tonsil with purified ab137872 at a working dilution of 1/500. The secondary antibody used is ab97051 an HRP-conjugated goat anti-rabbit IgG (H+L) at a dilution of 1/500. The sample is counter-stained with hematoxylin. Antigen retrieval was perfomed using Tris-EDTA buffer pH 9.0. PBS was used instead of the primary antibody as the negative control and is shown in the inset.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LEF1 antibody [EPR2029Y] (AB137872)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LEF1 antibody [EPR2029Y] (AB137872)

Immunohistochemical staining of paraffin-embedded human thymus with purified ab137872 at a working dilution of 1/500. The secondary antibody used is ab97051 an HRP-conjugated goat anti-rabbit IgG (H+L) at a dilution of 1/500. The sample is counter-stained with hematoxylin. Antigen retrieval was perfomed using Tris-EDTA buffer pH 9.0. PBS was used instead of the primary antibody as the negative control and is shown in the inset.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LEF1 antibody [EPR2029Y] (AB137872)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LEF1 antibody [EPR2029Y] (AB137872)

Immunohistochemical analysis of formalin fixed paraffin embedded human tonsil labelling LEF1 with ab137872 at a concentration of 0.5 µg/ml. The immunostaining was performed on a Ventana DISCOVERY ULTRA (Roche Tissue Diagnostics) instrument with an OptiView DAB IHC Detection Kit. Heat mediated antigen retrieval was conducted for 32 mins at 100°C with ULTRA cell conditioning solution (CC1, pH 8.5). ab137872 anti LEF1 antibody [EPR2029Y] was incubated at 37°C for 16 mins. Sections were counterstained with Hematoxylin II. Image inset shows absence of staining in secondary antibody only control.

Immunoprecipitation - Anti-LEF1 antibody [EPR2029Y] (AB137872)
  • IP

Lab

Immunoprecipitation - Anti-LEF1 antibody [EPR2029Y] (AB137872)

Lane 1 (input) : Jurkat (human T cell leukemia T lymphocyte) whole cell lysate, 10 μg
Lane 2 (+) : Jurkat whole cell lysate
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab137872 in Jurkat whole cell lysate

ab137872 immunoprecipitating LEF1 in Jurkat whole cell lysate. For western blotting, primary antibody used was ab137872 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10,000 dilution.

Blocking and diluting buffer : 5% NFDM/TBST

Exposure time : 3 minutes

All lanes:

Immunoprecipitation - Anti-LEF1 antibody [EPR2029Y] (ab137872)

Predicted band size: 44 kDa

false

Exposure time: 3min

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LEF1 antibody [EPR2029Y] (AB137872)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LEF1 antibody [EPR2029Y] (AB137872)

ab137872 staining LEF1 in paraffin embedded human melanoma tissue by Immunohistochemistry. Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0 Epitope Retrieval Solution2) for 20 mins.  Samples were incubated with primary antibody at 1/2000 dilution for 30 mins at room temperature. A ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101) was used as the secondary antibody. Hematoxylin was used as a counterstain. The immunostaining was performed on a Leica Biosystems BOND® RX instrument.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LEF1 antibody [EPR2029Y] (AB137872)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LEF1 antibody [EPR2029Y] (AB137872)

ab137872 staining LEF1 in paraffin embedded mouse spleen tissue by Immunohistochemistry. Antigen retrieval was performed by heat mediation using ab93684 (Tris/EDTA buffer, ph 9). Samples were incubated with primary antibody at 1/2000 dilution. A ready to use Goat Anti-rabbit IgG H&L (HRP) was used as the secondary antibody. Hematoxylin was used as a counterstain. Nuclear staining on T cells in periarterial lymphatic sheath of mouse spleen is observed (PMID : 21685909).

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LEF1 antibody [EPR2029Y] (AB137872)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LEF1 antibody [EPR2029Y] (AB137872)

Immunohistochemical staining of paraffin embedded rat spleen with purified ab137872 at a working dilution of 1/500. The secondary antibody used is ab97051, an HRP-conjugated goat anti-rabbit IgG (H+L), at a dilution of 1/500. The sample is counter-stained with hematoxylin. Antigen retrieval was perfomed using Tris-EDTA buffer, pH 9.0. PBS was used instead of the primary antibody as the negative control, and is shown in the inset.

Immunoprecipitation - Anti-LEF1 antibody [EPR2029Y] (AB137872)
  • IP

Lab

Immunoprecipitation - Anti-LEF1 antibody [EPR2029Y] (AB137872)

Lane 1 (input) : Rat thymus lysate, 10μg
Lane 2 (+) : Rat thymus lysate
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab137872 in rat thymus lysate

ab137872 immunoprecipitating LEF1 in rat thymus lysate. For western blotting, primary antibody used was ab137872 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10,000 dilution.

Blocking and diluting buffer : 5% NFDM/TBST

Exposure time : 3 minutes

All lanes:

Immunoprecipitation - Anti-LEF1 antibody [EPR2029Y] (ab137872)

Predicted band size: 44 kDa

false

Exposure time: 3min

Western blot - Anti-LEF1 antibody [EPR2029Y] (AB137872)
  • WB

Lab

Western blot - Anti-LEF1 antibody [EPR2029Y] (AB137872)

Different batches of ab137872 were tested on Jurkat (Human T cell leukemia T lymphocyte) lysate at 1.1 µg/ml. 15 µg of lysate was loaded in each lane. Bands observed at 25-57 kDa.

All lanes:

Western blot - Anti-LEF1 antibody [EPR2029Y] (ab137872)

Predicted band size: 44 kDa

false

Western blot - Anti-LEF1 antibody [EPR2029Y] (AB137872)
  • WB

Lab

Western blot - Anti-LEF1 antibody [EPR2029Y] (AB137872)

False colour image of Western blot : Anti-LEF1 antibody [EPR2029Y] staining at 1/1000 dilution, shown in black; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab137872 was shown to bind specifically to LEF1. A band was observed at 40/53 kDa in wild-type Jurkat cell lysates with no signal observed at this size in Lef1 knockout cell line ab274898 (knockout cell lysate ab274956). To generate this image, wild-type and Lef1 knockout Jurkat cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3% milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times before development with Optiblot (ECL reagent ab133456) and imaged with 4 minutes exposure time. Secondary antibodies used were HRP conjugated Goat anti-Rabbit (H+L) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.

All lanes:

Western blot - Anti-LEF1 antibody [EPR2029Y] (ab137872) at 1/1000 dilution

Lane 1:

Wild-type Jurkat cell lysate at 40 µg

Lane 2:

Lef1 knockout Jurkat cell lysate at 40 µg

Lane 2:

Western blot - Human LEF1 knockout Jurkat cell line (<a href='/products/cell-lines/human-lef1-knockout-jurkat-cell-line-ab274898'>ab274898</a>)

Lane 3:

Jurkat cell lysate at 20 µg

Predicted band size: 44 kDa

Observed band size: 40 kDa

false

Western blot - Anti-LEF1 antibody [EPR2029Y] (AB137872)
  • WB

Unknown

Western blot - Anti-LEF1 antibody [EPR2029Y] (AB137872)

Blocking/Dilution buffer : 5% NFDM/TBST

All lanes:

Western blot - Anti-LEF1 antibody [EPR2029Y] (ab137872) at 1/10000 dilution

All lanes:

Jurkat (Human T cell leukemia cell line from peripheral blood) cell lysate at 10 µg

Secondary

All lanes:

HRP goat anti-rabbit (H+L) at 1/1000 dilution

Predicted band size: 44 kDa

false

Western blot - Anti-LEF1 antibody [EPR2029Y] (AB137872)
  • WB

Unknown

Western blot - Anti-LEF1 antibody [EPR2029Y] (AB137872)

Blocking/Dilution buffer : 5% NFDM/TBST

All lanes:

Western blot - Anti-LEF1 antibody [EPR2029Y] (ab137872) at 1/1000 dilution

All lanes:

Human fetal thymus lysate at 10 µg

Secondary

All lanes:

HRP goat anti-rabbit (H+L) at 1/1000 dilution

Predicted band size: 44 kDa

false

Western blot - Anti-LEF1 antibody [EPR2029Y] (AB137872)
  • WB

Unknown

Western blot - Anti-LEF1 antibody [EPR2029Y] (AB137872)

Blocking/Dilution buffer : 5% NFDM/TBST

All lanes:

Western blot - Anti-LEF1 antibody [EPR2029Y] (ab137872) at 1/2000 dilution

All lanes:

Rat thymus tissue lysate at 20 µg

Secondary

All lanes:

HRP goat anti-rabbit (H+L) at 1/1000 dilution

Predicted band size: 44 kDa

false

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LEF1 antibody [EPR2029Y] (AB137872)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LEF1 antibody [EPR2029Y] (AB137872)

Tissue Microarrays stained for Anti-LEF1 antibody [EPR2029Y] using ab137872 in immunohistochemical analysis. This table provides a detailed overview of positive (tick mark) and negaive (cross mark) staining per sample type tested. The sections were incubated with ab137872 for 30 mins at room temperature used at 1 : 2000 dilution (1.05 μg/ml) followed by a ready to use Rabbit specific IHC polymer detection kit HRP/DAB secondary antibody (ab209101). Counterstain was Hematoxylin. Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins. The immunostaining was performed on a Leica Biosystems BOND® RX instrument.

Western blot - Anti-LEF1 antibody [EPR2029Y] (AB137872)
  • WB

Lab

Western blot - Anti-LEF1 antibody [EPR2029Y] (AB137872)

Blocking and diluting buffer : 5% NFDM/TBST

All lanes:

Western blot - Anti-LEF1 antibody [EPR2029Y] (ab137872) at 1/1000 dilution

All lanes:

His-tagged mouse LEF-1 recombinant protein (aa1-397) at 0.01 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 44 kDa

Observed band size: 44 kDa

false

Exposure time: 1s

不同偶联物与剂型 (4)

  • HRP

    HRP Anti-LEF1 antibody [EPR2029Y]

  • Carrier free

    Anti-LEF1 antibody [EPR2029Y] - BSA and Azide free

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-LEF1 antibody [EPR2029Y]

  • 660 APC

    APC Anti-LEF1 antibody [EPR2029Y]

关键信息

宿主种属

Rabbit

克隆

Monoclonal

克隆号

EPR2029Y

亚型

IgG

不含载体蛋白

No

反应种属

Mouse, Rat, Human

应用

IP, IHC-P, WB, ICC/IF, Flow Cyt (Intra)

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

反应性数据

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100 - 1/500", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.", "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p>We don't recommend this antibody for mouse in Western Blot. In our hands an extra band was observed in mouse tissue lysates.</p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/500", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "<p></p>" }, "Mouse": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100 - 1/500", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.", "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "guaranteed", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "guaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" }, "Rat": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100 - 1/500", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.", "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p>We don't recommend this antibody for mouse in Western Blot. In our hands an extra band was observed in mouse tissue lysates.</p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "guaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" } } }

产品详情

Anti-LEF1 antibody [EPR2029Y] (ab137872) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt (Intra), ICC/IF, IHC-P, IP and WB.

Abcam's high quality manufacturing and validation processes ensure Anti-LEF1 antibody [EPR2029Y] (ab137872) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.

The specificity of Anti-LEF1 antibody [EPR2029Y] (ab137872) has been confirmed by Western Blot testing in LEF1 knockout Jurkat cells (ab274898).

Anti-LEF1 antibody [EPR2029Y] (ab137872) specifically detects LEF1 (UniProt ID: Q9UJU2; Molecular weight: 45kDa) and is sold in a convenient trial size to enable initial testing (20 µL) and larger sizes for subsequent scaling up experiments (100 µL and 1 mL).

Conjugation-ready, carrier free format available for antibody clone EPR2029Y - ab215999.

Antibody clone EPR2029Y is also available pre-conjugated to a variety of labels for your convenience - HRP, Alexa Fluor® 647, APC (ab197623, ab246715, ab314938).

LEF1 is a transcription factor that promotes tumorigenicity in various cancers by activating pathways like TGF-β. LEF1 also plays a role in maintaining cancer stem cell properties, contributing to chemoresistance and metastasis.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

性能和储存信息

形式
Liquid
纯化工艺
Affinity purification Protein A
存储溶液
Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
运输条件
Blue Ice
推荐的短期储存时间
1-2 weeks
推荐的短期储存条件
+4°C
推荐的长期储存条件
-20°C
分装信息
Upon delivery aliquot
储存信息
Avoid freeze / thaw cycle

补充信息

This supplementary information is collated from multiple sources and compiled automatically.

LEF1 (Lymphoid Enhancer-Binding Factor 1) also known as LEF-1 or LEF 1 functions as a transcription factor involved in Wnt signaling pathways. The LEF1 protein has a mass of about 45 kilodaltons. Expression of LEF1 occurs mainly in lymphoid tissues and the central nervous system. Researchers often use LEF1 in immunohistochemistry (LEF1 IHC) for its ability to bind DNA at specific sites regulating gene expression important for cellular development and differentiation especially in T cells such as Jurkat cells.
Biological function summary

LEF1 plays a significant role in the regulation of cell fate decisions and development. It acts as part of a transcription complex that binds to specific DNA sequences facilitating the transcription of target genes. LEF1 interacts with β-catenin and this interaction is essential for the regulation of gene expression during embryonic development and cellular proliferation. LEF1's biological functions make it a useful marker in various research applications and assays like LEF1 ELISA are often utilized to study its expression levels in different physiological contexts.

Pathways

LEF1 is a central player in the canonical Wnt/β-catenin signaling pathway. This pathway is fundamental for processes like embryogenesis and cellular growth. LEF1 interacts closely with proteins such as TCF (T-cell factor) family members and β-catenin to regulate gene expression. Disruption in the Wnt pathway where LEF1 is significant can lead to abnormal cell growth and differentiation. Consequently LEF1 serves as an indicator and potential regulator of pathway activities in various cellular environments.

LEF1 is associated with numerous conditions particularly in oncology and immunology. Aberrations in LEF1 expression contribute to diseases like leukemia and lymphoma. Overexpression or mutations of LEF1 might lead to unregulated Wnt signaling promoting cancer progression. Furthermore LEF1's interactions with proteins such as MYC a well-known oncogene highlight its importance in tumorigenesis. Understanding LEF1's mechanisms can offer insights into therapeutic targets for these diseases providing a pathway for research into drug development and intervention strategies.

产品实验方案

For this product, it's our understanding that no specific protocols are required. You can visit:

靶点信息

Transcription factor that binds DNA in a sequence-specific manner (PubMed : 2010090). Participates in the Wnt signaling pathway (By similarity). Activates transcription of target genes in the presence of CTNNB1 and EP300 (By similarity). PIAG antagonizes both Wnt-dependent and Wnt-independent activation by LEF1 (By similarity). TLE1, TLE2, TLE3 and TLE4 repress transactivation mediated by LEF1 and CTNNB1 (PubMed : 11266540). Regulates T-cell receptor alpha enhancer function (PubMed : 19653274). Required for IL17A expressing gamma-delta T-cell maturation and development, via binding to regulator loci of BLK to modulate expression (By similarity). Acts as a positive regulator of odontoblast differentiation during mesenchymal tooth germ formation, expression is repressed during the bell stage by MSX1-mediated inhibition of CTNNB1 signaling (By similarity). May play a role in hair cell differentiation and follicle morphogenesis (By similarity).. Isoform 1. Transcriptionally activates MYC and CCND1 expression and enhances proliferation of pancreatic tumor cells.. Isoform 3. Lacks the CTNNB1 interaction domain and may therefore be an antagonist for Wnt signaling.. Isoform 5. Transcriptionally activates the fibronectin promoter, binds to and represses transcription from the E-cadherin promoter in a CTNNB1-independent manner, and is involved in reducing cellular aggregation and increasing cell migration of pancreatic cancer cells.
See full target information LEF1_HUMAN

文献 (96)

Recent publications for all applications. Explore the full list and refine your search

Frontiers in medicine 12:1636860 PubMed40933575

2025

Identification of novel gut microbiota-related biomarkers in cerebral hemorrhagic stroke.

Applications

Unspecified application

Species

Unspecified reactive species

Fengli Ye,Huili Li,Hongying Li,Xiue Mu

BMC biology 23:268 PubMed40859304

2025

Cranial base synostosis in mice caused by upregulation of Wnt following partial inhibition of Shh.

Applications

Unspecified application

Species

Unspecified reactive species

Jiangping Chen,Chengyan Ren,Chuanqing Mao,Yongzhen Lai,Meng Lu,Yuanjing Jiang,Weihui Chen

Nature communications 16:7824 PubMed40841542

2025

Changes in cellular composition shape the inductive properties of Hensen's Node.

Applications

Unspecified application

Species

Unspecified reactive species

Tatiane Y Kanno,Megan Rothstein,Marcos Simoes-Costa

Research (Washington, D.C.) 8:0828 PubMed40809457

2025

Isovalerylspiramycin I Reprograms the Immunosuppressive and Temozolomide-Resistant Microenvironment by Inhibiting the Frizzled-5/Wnt/β-Catenin Pathway in Glioblastoma.

Applications

Unspecified application

Species

Unspecified reactive species

Xin Luo,Xiangyang Zhong,Tianci Zeng,Xiaodie Li,Tao Yang,Qu Yue,Yufei Lan,Sui Chen,Zhao Wang,Manqing Zhang,Boming Zuo,Yuankai Wang,Yixiong Shen,Jiankun Lu,Boyang Liu,Hongbo Guo

Nature communications 16:4280 PubMed40399281

2025

Gonadotrophs have a dual origin, with most derived from early postnatal pituitary stem cells.

Applications

Unspecified application

Species

Unspecified reactive species

Daniel Sheridan,Probir Chakravarty,Gil Golan,Yiolanda Shiakola,Jessica Olsen,Elise Burnett,Christophe Galichet,Tatiana Fiordelisio,Patrice Mollard,Philippa Melamed,Robin Lovell-Badge,Karine Rizzoti

Journal of orthopaedic surgery and research 20:430 PubMed40301985

2025

USP2-induced upregulation of LEF1 through deubiquitination relieves osteoporosis development by promoting the osteogenic differentiation of bone marrow mesenchymal stem cells.

Applications

Unspecified application

Species

Unspecified reactive species

Zhihong Zhang,Jie Cao,Hanwen Xing,Jing Liu,Linshuo Li,Yue Zhang

Journal of clinical pathology : PubMed39653501

2024

Lymphoid enhancer-binding factor 1 (LEF1) immunostaining as a surrogate for β-catenin () mutations.

Applications

Unspecified application

Species

Unspecified reactive species

Ekkehard Hewer,Pascal David Fischer,Erik Vassella,Laura Knabben,Sara Imboden,Michael D Mueller,Tilman T Rau,Matthias S Dettmer

Medicine 103:e39892 PubMed39465830

2024

LEF1 is associated with immunosuppressive microenvironment of patients with lung adenocarcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaoqing Liu,Chunlou Wang,Xiaoling Zhang,Rongju Zhang

Journal of nanobiotechnology 22:425 PubMed39030543

2024

Exosomes derived from mouse vibrissa dermal papilla cells promote hair follicle regeneration during wound healing by activating Wnt/β-catenin signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Yage Shang,Mengyang Li,Lixia Zhang,Chao Han,Kuo Shen,Kejia Wang,Yan Li,Yue Zhang,Liang Luo,Yanhui Jia,Kai Guo,Weixia Cai,Jian Zhang,Xujie Wang,Hongtao Wang,Dahai Hu

Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society 32:279-291 PubMed38353052

2024

Film-forming polymer solutions containing cholesterol myristate and berberine mediate pressure ulcer repair via the Wnt/β-catenin pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Yu Li,Haiting Huang,Cuijin Gu,Wenyi Huang,Xianxian Chen,Xiaoting Lu,Aijia You,Sen Ye,Jun Zhong,Yao Zhao,Yu Yan,Chun Li
View all publications

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂,为您科研的每一步提供支持。若我们的产品未能达到预期性能,我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com